Abstract
New psychopharmacotherapy dilemmas associated with COVID-19 – case report
- Department of Psychiatry, Pomeranian Medical University in Szczecin
Case study
Due to the current pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS CoV-2), it is necessary to take therapeutic decisions con cerning the simultaneous use of psychopharmacology and drugs supporting the elimination of the virus, es pecially chloroquine.
Opis przypadku
A 36-year-old female patient, with a diag nosis of paranoid schizophrenia, treated with clozapine, zuclopenthixol and lamotrigine, was diagnosed with SARS-CoV-2 infection. Following the recommendations of a specialist of infectious diseases, azithromycin and chloroquine were introduced to the treatment. Due to po tential drug interactions, morphology, AST, ALT and ECG were monitored. No abnormalities of monitored parame ters were observed. The virus was effectively eliminated.
Comments
With appropriate patient monitoring and care, antipsychotics were successfully combined with chloroquine and azithromycin in short-term therapy of lung inflammatory changes associated with SARS-CoV-2 infection.
Keywords
antipsychotics, chlorochina, SARS-CoV-2
Integrated with
